NEU neuren pharmaceuticals limited

Angelman trial, page-29

  1. 4 Posts.
    Not sure if Ion582 is cause of share price weakness.It is delivered by intrathecal injection which has some risks associated with serious infections and potential cord damage. Also presume sedation or anaesthetic needed to deliver.
    Interesting to see more detail but seems complex and potentially a risk in delivering as opposed to a safe well tolerated oral medication.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.91
Change
1.370(10.9%)
Mkt cap ! $1.730B
Open High Low Value Volume
$12.96 $14.00 $12.91 $8.495M 621.6K

Buyers (Bids)

No. Vol. Price($)
15 424 $13.89
 

Sellers (Offers)

Price($) Vol. No.
$13.91 674 5
View Market Depth
Last trade - 11.47am 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.